[Guideline for hyperlipidemia]

Mitsuru Seishima1

  • 1Department of Clinical Laboratory Medicine, Gifu University School of Medicine, Gifu 500-8705.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|July 30, 2003
PubMed

Insights

The Japan Atherosclerosis Society (JAS) guidelines for hyperlipidemia diagnosis and treatment were updated in 2002, maintaining previous diagnostic values for cholesterol and triglycerides. Lifestyle changes are recommended before drug therapy for abnormal results.

Area of Science:

  • Cardiovascular Medicine
  • Public Health

Background:

  • The Japan Atherosclerosis Society (JAS) has developed guidelines for managing atherosclerotic cardiovascular diseases since 1987.
  • Previous guidelines were published in 1997, with significant updates in 2002.

Purpose of the Study:

  • To present the updated JAS guidelines for the diagnosis and treatment of atherosclerotic cardiovascular diseases.
  • To define diagnostic criteria and management goals for hyperlipidemia and coronary heart disease.

Main Methods:

  • The 2002 guidelines incorporated findings from the J-LIT study and other relevant research.
  • Diagnostic values for total cholesterol (TC), LDL-C, HDL-C, and triglycerides (TG) were established.
  • Management goals were set for coronary heart disease patients based on risk factor stratification.

Main Results:

  • Diagnostic criteria for hyperlipidemia: TC ≥ 220 mg/dL, LDL-C ≥ 140 mg/dL, HDL-C < 40 mg/dL, TG ≥ 150 mg/dL.
  • Recommended TC level for males < 45 with no risk factors is < 240 mg/dL.
  • Treatment initiation prioritizes lifestyle and dietary modifications over drug therapy for abnormal results.

Conclusions:

  • The updated JAS guidelines provide a framework for diagnosing and managing atherosclerotic cardiovascular diseases.
  • Physician's clinical judgment remains paramount in determining individual patient treatment plans.
  • Emphasis is placed on a stepwise approach to treatment, starting with lifestyle interventions.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...